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Lipid levels in plasma strongly influence the risk for coronary heart disease. To localise and subsequently
identify genes affecting lipid levels, we performed four genome-wide linkage scans followed by combined
linkage/association analysis. Genome-scans were performed in 701 dizygotic twin pairs from four samples
with data on plasma levels of HDL- and LDL-cholesterol and their major protein constituents,
apolipoprotein AI (ApoAI) and Apolipoprotein B (ApoB). To maximise power, the genome scans were
analysed simultaneously using a well-established meta-analysis method that was newly applied to linkage
analysis. Overall LOD scores were estimated using the means of the sample-specific quantitative trait locus
(QTL) effects inversely weighted by the standard errors obtained using an inverse regression method.
Possible heterogeneity was accounted for with a random effects model. Suggestive linkage for HDL-C was
observed on 8p23.1 and 12q21.2 and for ApoAI on 1q21.3. For LDL-C and ApoB, linkage regions frequently
coincided (2p24.1, 2q32.1, 19p13.2 and 19q13.31). Six of the putative QTLs replicated previous findings.
After fine mapping, three maximum LOD scores mapped within 1 cM of major candidate genes, namely
APOB (LOD¼ 2.1), LDLR (LOD¼1.9) and APOE (LOD¼1.7). APOB haplotypes explained 27% of the QTL
effect observed for LDL-C on 2p24.1 and reduced the LOD-score by 0.82. Accounting for the effect of the
LDLR and APOE haplotypes did not change the LOD score close to the LDLR gene but abolished the linkage
signal at the APOE gene. In conclusion, application of a new meta-analysis approach maximised the power
to detect QTLs for lipid levels and improved the precision of their location estimate.
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Introduction
The risk of coronary heart disease is influenced by genetic
factors. Identification of the underlying variation in genes
and other genomic sequences may provide valuable in-
sights into the biological pathways contributing to cor-
onary heart disease. Achieving this goal by investigating
the disease itself in human genetic studies is challenging.
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Patients diagnosed with the same disease will frequently
have been exposed to genetic disturbances of different
biological pathways. A powerful alternative approach is the
analysis of quantitative intermediate phenotypes correlat-
ing with disease risk.1,2 For coronary heart disease, LDL-
and HDL-cholesterol are well-characterised intermediate
phenotypes.1
LDL particles contribute to coronary heart disease by
accumulating in the vessel wall thus forming a lipid core
and initiating various cellular responses that promote
atherosclerosis.3 LDL particles contain one molecule of
the protein apolipoprotein B (ApoB), which serves as a
ligand for receptors such as the LDL-receptor. Hence, levels
of LDL-C and ApoB in plasma are highly correlated. The
function of HDL particles is to transport cholesterol from
peripheral tissues, including from LDL particles trapped in
the vessel wall, back to the liver.4 The major protein consti-
tuent of HDL, apolipoprotein AI (ApoAI), mediates the up-
take of cholesterol. HDL particles contain a varying number
of ApoAI molecules.5 Therefore, levels of HDL-C and ApoAI
are correlated although less strong than LDL-C and ApoB.
Importantly, interindividual variation in plasma levels of
LDL-C, HDL-C and their main apolipoproteins is consi-
derably heritable,6,7 which provides the rationale for studies
aimed at identifying the underlying genetic variation.
A commonly adopted strategy to disentangle the genetic
basis of complex phenotypes is localisation using a
genome-wide linkage scan in families followed by identi-
fication using association approaches to scrutinise genetic
variation in positional candidate genes. For lipid research,
the power of this approach is illustrated by the recent
identification of the USF1 as a gene involved in familial
combined hyperlipidaemia.8 Notwithstanding successes
like this and others,2 genome-wide scans have attracted
criticism for their relatively low statistical power and
consequently high rate of false negative results.9 An
advantage of genome-wide scans, however, is that the
design allows detecting the effects of multiple, individually
rare allelic variants at a locus. Alternative approaches, like
(genome-wide) association studies that rely on common
single-nucleotide polymorphisms (SNPs) to tag haplotypes,
depend on the validity of the ‘common disease, common
variant’ hypothesis, which may not apply to all genetic
variation influencing complex traits. Indeed, evolutionary
models predicted rare variants to make up a large part of
the genetic risk for common diseases,10 and recently mul-
tiple rare variants of candidate genes were shown to signifi-
cantly contribute to variation in HDL-C in the general
population.11 Hence, despite the concern of low power,
genome-wide linkage scans may remain one of the major
tools to map loci contributing to complex traits. Therefore,
developing new analysis methods is vital to overcome the
relatively low power of the study design. Meta-analysis
methods that allow the simultaneous analysis of multiple
genome scans are among the most promising solutions.
We performed four autosomal genome-wide linkage
scans to localise quantitative trait loci (QTLs) influencing
LDL-C and HDL-C and their major apolipoproteins, ApoB
and ApoAI. To maximise power, data from the four twin
populations were combined using a well-established meta-
analysis method12,13 newly applied to linkage analysis. The
method estimates an overall LOD score using the mean of
the sample-specific QTL effects weighted by the precision of
these estimates (ie inversely weighted by their standard
errors (SEs)). Next, the influence of haplotypes of positional
candidates was tested within the same framework.
Subjects and methods
Subjects
The current study was performed using twin studies from
three countries:7 Australia (Semi-Structured Assessment for
the Genetics of Alcoholism Study), The Netherlands
(Netherlands Twin Registry) and Sweden (Adoption/Twin
Study of Aging); from The Netherlands two twin samples
were used: an adolescent and an adult sample. All twins
were recruited without regard to any trait or disease status
and may thus be regarded as representing the general
population. Zygosity was initially determined using stan-
dard questionnaires on physical similarity and the degree to
which others confused them (Australia, Netherlands Adult)
or serological markers (Netherlands adolescent, Sweden).
Subsequently, the relationship of dizygotic (DZ) twin pairs
was checked using short tandem repeat markers measured in
the genome scan with the software GRR.14 Phenotypes and
genotypes were available for 457 Australian, 83 adolescent
Dutch, 117 adult Dutch and 44 Swedish DZ twin pairs.
In addition, 76 parents and 75 siblings of Australian DZ
twins without phenotypic data were genotyped to
improve the estimate of the proportion of alleles shared
identical-by-descent (IBD). One adult Dutch family and
five Australian families had two DZ twin pairs and were
analysed as such.
Phenotyping
Phenotyping was performed as described previously.7
Briefly, blood samples were taken after an overnight fast
except for the Australian twins. HDL-C levels were
measured in plasma after precipitation of ApoB-containing
lipoproteins. Plasma ApoB and ApoAI were measured using
a Behring nephelometer (Australia), radial immunodiffu-
sion (Netherlands adolescent), Beckman Instruments’
Array Protein System (Netherlands adult) or a radio-
immunoassay (Sweden). LDL-C was calculated using the
Friedewald formula (LDL-C¼ total cholesterolHDL-
C(triglycerides/2.2); unit mmol/l) and set to missing if
plasma triglyceride concentration exceeded 4.52 mmol/l.
Plasma levels of total cholesterol and triglycerides were
determined using standard enzymatic methods.
Four genome scans for lipid levels
BT Heijmans et al
1144
European Journal of Human Genetics
Genotyping
Short tandem repeat polymorphisms A 395 marker
genome scan (B10 CM spacing) was performed in Dutch,
Swedish and half of the Australian DZ pairs (n¼ 250) by the
Molecular Epidemiology Section, Leiden University Medi-
cal Centre, The Netherlands. The scan was performed in
several phases. First, chromosome 19 was scanned using in-
house markers at an B8 CM spacing using an ALFexpress
automated sequencer (Amersham Pharmacia Biotech) as
described previously.15 Next, chromosomes 1, 2, 6, 7, 8, 11,
15, 16 and 17 were scanned at an 18 CM spacing on the
basis of early power calculations16 with markers from
Weber screening set 8 using an ALFexpress automated
sequencer. While the scan was ongoing, results from other
genome scans showed that an 18 CM spacing is too sparse.
Therefore, additional markers were measured on these
chromosomes to decrease the spacing to B10 CM. These
markers were taken from the Human Linkage Set v2.5
MD10 and HD5 (Applied Biosystems) and measured using
an ABI Prism DNA Analyzer 3700 (Applied Biosystems).
The remaining chromosomes were finished with the 10 CM
Human Linkage Set v2.5 MD10 and the same equipment.
Genotyping was performed according to the manufacturer
except that the amount of primer pairs for the markers was
reduced up to five-fold and duplex PCR reactions were
designed if possible to reduce costs, time expense and
amount of genomic DNA used. Lastly, fine mapping was
performed for promising linkage regions on chromosomes
2 and 19 with 12 and 9 markers, respectively, from the
Human Linkage Set v2.5 MD10 and HD5. Genotyping was
carried out using Fragment Analyser 1.02 (Amersham
Pharmacia Biotech) when using ALFexpress equipment
and Genemapper 2.0 and 3.0 (Applied Biosystems) when
using an ABI Prism DNA Analyzer 3700. For the purpose of
quality control,B5% of samples were genotyped twice and
the results compared. These comparisons indicated that
markers D5S416, D9S158, D11S4175, D12S86, D14S68,
D18474 and D19S209 from the Human Linkage Set v2.5
MD10 could not be genotyped reliably in our hands due to
unstable ratio of the signal of the long and short allele, low
success rate or unclear 1-bp alleles.
An additional 730 marker genome scan (B5 CM spacing)
was carried out in 354 Australian DZ pairs by the Mammalian
Genotyping Service, Center for Medical Genetics, Marsh-
field, USA. Two marker sets were used: screening set 13 and
52. Marker ATA27C11 had 1-bp alleles and showed an
excessive noncorrespondence rate when genotypes were
compared for eight samples that were genotyped in dupli-
cate. This marker was removed prior to statistical analysis.
There was an overlap of 147 Australian pairs between the
scans carried out in Leiden and in Marshfield so that the
total number of scanned Australian DZ pairs is 457.
Mendelian errors were detected using PEDSTATS and un-
likely double recombinants using MERLIN.17 A locally
developed SQL server database was used to store genotypic
data, compare repeated genotypings, integrate the Leiden
and Marshfield genome scans and generate files for linkage
analysis. The location of the markers was taken from an
integrated genetic map with interpolated genetic map posi-
tions (http://www2.qimr.edu.au/davidD/). The position is in
Decode CM, estimated via locally weighted linear regression
(lo(w)ess) from the Build 34.3 physical map positions and
published Decode and Marshfield genetic map positions.
Single-nucleotide polymorphisms Tagging SNPs in the
genes APOB, LDLR and APOE were selected from litera-
ture18 – 20 and associated databases on the web (APOB:
rs512535 (837G/A; minor allele frequency (MAF) in
Australian sample¼0.48), rs934197 (516C/T;
MAF¼0.34), rs693 (T2488T; MAF¼0.46), rs676210
(P2712L; MAF¼0.22), rs1801701 (R3611Q; MAF¼0.10),
rs1042031 (E4154K; MAF¼0.18); LDLR: rs6511720
(MAF¼ 0.12), rs8102912 (MAF¼0.24), rs6511721
(MAF¼ 0.49), rs12980593 (MAF¼0.47), rs5925 (AvaII;
MAF¼0.45), rs2738459 (MAF¼ 0.46), rs13306506 (MspIa;
MAF¼0.24), rs1433099 (MspIb; MAF¼0.27); APOE:
rs449647 (491A/T; MAF¼0.19), rs405509 (219G/T;
MAF¼0.42), rs769450 (MAF¼0.49), rs429358 (e3/e4;
MAF¼0.14), rs7412 (e3/e2; MAF¼0.08)). The two APOE
SNPs underlying the e2/e3/e4 isoforms were measured using
PCR followed by HhaI digestion. For the remaining 17
SNPs, Assay Designer software (Sequenom) was used to
design multiplex genotyping assays.21 Genotyping was
performed using the MassArray platform according to the
protocols of the manufacturer (Sequenom). Briefly, after
PCR, a primer extension reaction was performed to intro-
duce mass-differences between alleles and, after removing
salts by adding a resin, B15 nl of the product was spotted
onto a target chip with 384 patches containing matrix.
Mass differences were detected using matrix-assisted laser
desorption\ionisation time-of-flight mass spectrometry
(MALDI-TOF) and genotypes were assigned real-time using
Typer 3.0 software (Sequenom). As quality control, cluster
plots were made of the low and high mass allele signals as
detected using mass spectrometry. Calls falling outside a
cluster and no-calls falling inside a cluster were checked
manually. In addition, 5–10% of samples were genotyped
in duplicate and no inconsistencies were observed.
Statistical analysis
Prior to analysis, phenotypes were transformed by the
natural logarithm if appropriate (this was the case for all
phenotypes but LDL-C in the Australian and LDL-C and
ApoB in the adult Dutch sample), adjusted for sex and age
and standardised, for each study population separately, so
that all phenotypes had a mean of 0 and a standard
deviation of 1. Phenotypic values of individuals using
statins were included in the analysis without correction (11
Australian DZ twins from 10 pairs and four adult Dutch DZ
twins from four pairs). To check the validity of this
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approach, the linkage analysis was repeated after excluding
statin users, which did not materially alter the results for
LDL-C and ApoB levels.
Linkage analysis was performed using an inverse regres-
sion method22 implemented as MERLIN-REGRESS in the
software MERLIN. This method regresses the estimated
proportion of alleles shared IBD on the squared sums and
squared differences of standardised trait values of the
relative pairs and yields an estimate of the QTL effect and
its SE. Although designed for selected samples, this inverse
regression method has asymptotically equivalent power to
variance components linkage analysis for random sam-
ples,23 but has advantages that it is fast and less sensitive to
the assumption of multivariate normality than variance
components analysis. Inverse regression needs the herit-
ability of the phenotype to be specified, which has the
advantage that an appropriate upper limit for the estima-
tion of QTL effects is obtained and the risk of over-
estimation is reduced.24 Heritabilities of standardised and
age and sex adjusted phenotypes were estimated for each
study population separately using variance components
analysis as implemented in the software QTDT.25 For this
analysis, data on both monozygotic and DZ twins were
used. Only the genetic (heritability) and unique environ-
mental variances were estimated since previous work
showed that neither dominance nor common environ-
ment affected the variance.7 Heritabilities of lipid pheno-
types were greater than 0.50 in all samples generally being
somewhat lower among the Australian twins and highest
among adolescent Dutch twins.7 Sample-specific heritabil-
ities and allele frequencies of short tandem repeat poly-
morphisms (for estimation of the proportion of alleles
shared IBD) were used in the linkage analysis.
After analysing the four twin samples separately on a
common 1 CM grid using the inverse regression method,
the four QTL effects and their corresponding SEs were
combined into a single QTL effect estimate and SE using
meta-analytic tools that account for heterogeneity.12,13 The
single QTL effect estimate was calculated as the mean of
the sample-specific QTL effects weighted by their precision
(ie inversely weighted by their SE). Meta-analysis under
heterogeneity acknowledges the fact that the true QTL
effect may be different in different samples, and attempts
to estimate the mean QTL effect around which these
sample-specific QTL effects vary (using a random effects
model). If no heterogeneity exists, the power of the meta-
analysis method accounting for heterogeneity is the same
as the method assuming homogeneity (ie without random
effects model). The overall LOD score for each location was
calculated using the weighted mean QTL effect (b) and its
standard error (SE(b)), which can be converted into a
Z-score (Z¼ b/SE(b)) and subsequently into a LOD score
(LOD¼Z2/2*ln 10). The meta-analysis method has been
implemented in R (http://www.r-project.org/) and is avail-
able from the authors. A manuscript describing details on
how this meta-analysis method is applied to linkage
analysis is in preparation.
For putative QTLs that harboured well-known candidate
genes, it was tested whether genetic variation in these
genes contributed to the LOD score observed. If so, this
would lent support the linkages observed and the applied
meta-analysis method. This analysis was performed in
three steps for every twin sample separately. First, the
expectation-maximisation algorithm implemented in
SNPHAP was used to assign diplotypes (ie haplotype pairs)
to individuals (http://www-gene.cimr.cam.ac.uk/clayton/
software/). Diplotypes were assigned only if the probability
of the most likely haplotype was greater than 50%. Second,
the effect of haplotypes on lipid phenotypes was assessed
using a maximum likelihood method that simultaneously
estimates haplotype frequencies and haplotype–pheno-
type associations implemented in the software THESIAS.26
Table 1 Characteristics of four twin samples under investigation
Australia Netherlands adolescent Netherlands adult Sweden
Age 45.9 (11.7) 16.7 (2.0) 44.2 (6.6) 65.6 (8.4)
Male (%) 33.5 50.2 49.2 40
DZ pairs (n) 457 83 117 44
HDL-C (mmol/l) 1.44 (0.39)1 1.30 (0.27) 1.23 (0.35) 1.48 (0.43)6
ApoAI (g/l) 1.44 (0.28)2 1.39 (0.20) 1.72 (0.42) 1.40 (0.28)
LDL-C (mmol/l) 3.43 (0.97)3 2.64 (0.71) 3.67 (0.97)5 4.63 (1.23)7
ApoB (g/l) 0.98 (0.26)4 0.79 (0.17) 1.24 (0.34) 1.10 (0.24)
HDL/ApoAI
Total correlation 0.70 0.77 0.71 0.73
Genetic correlation 0.78 0.87 0.77 0.77
LDL-C/ApoB
Total correlation 0.79 0.80 0.88 0.82
Genetic correlation 0.87 0.83 0.94 0.85
Data are number, percentage or mean (SD).
1–7. Number of DZ twin pairs with incomplete data was 41 (for 1), 19 (for 2), 66 (25/66 because triglycerides 44.52 mmol/l; for 3), 18 (for 4), 1 (1/1
because triglycerides 44.52 mmol/l; for 5), 8 (for 6) and 6 (2/6 because triglycerides 44.52 mmol/l; for 7).
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Third, the estimated regression-coefficients associated
with the various haplotypes were used to adjust the
phenotypic value for the DZ twins and these haplotype-
adjusted values were used for linkage analysis. Prior to
haplotype analysis, QTDT was used to test for the presence
of population stratification by comparing the within- and
between-twin pair association of SNPs with the phenotypes
under study.
Results
In total, 701 DZ twin pairs were studied from four twin
samples: an Australian, an adolescent Dutch, an adult
Dutch and a Swedish sample (Table 1). There was a strong
correlation between levels of LDL-C and ApoB as well as
between levels of HDL-C and ApoAI in all four samples
(Table 1). Consistent with biology, the correlation between
HDL-C and ApoAI (40.70) was somewhat lower than that
between LDL-C and ApoB (40.79).
Genome-wide scans were performed on the four twin
samples and were analysed simultaneously using a meta-
analysis method. The principle of the meta-analysis
method is that it combines effect estimates from the four
twin samples inversely weighted by their SEs and is robust
to heterogeneity. The result of the genome scan for the
correlated lipid phenotypes HDL-C and ApoAI is shown in
Figure 1 Result of a meta-analysis of four genome-wide scans for plasma levels of HDL-C and ApoAI.
Table 2 Chromosomal regions yielding a LOD score41.5 in the simultaneous analysis of Australian, adolescent Dutch, adult
Dutch and Swedish twins
Chromosome
Position in cM
(Decode map) Marker
LOD score
HDL-C ApoAI
1p36.23 13 D1S1612 1.8 0.2
1q21.3 246 AAT243–AATA011 0.1 2.1
2p21 71 D2S391 0.3 1.7
3p14.2 81 GATA10H05 1.6 0.1
8p23.1 18 D8S1130 2.0 0.3
12q21.2 91 D12S326 2.2 0.2
LDL-C ApoB
2p25.1 25 D2S423 1.9 2.0
2p25.1a 25 D2S423 2.0 2.0
2p24.1 45 AAT263 1.6 2.1
2p24.1a 45 AAT263/D2S2150 2.1 2.1
2q31.2 184 D2Ss335–D2S1391 2.1 1.7
2q32.1a 187 D2S1391 2.0 1.7
5p15.33 0 D5S1981 1.6 0.3
19p13.12 37 D19S714 1.9 0.6
19p13.2a 33 D19S221 1.9 0.7
19q13.32 76 APOC2–D19S246 1.7 1.0
19q13.31a 73 APOC2 1.7 0.7
aAfter fine mapping.
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Figure 1. LOD scores greater than 1.5 were found on
chromosomes 1, 3, 8 and 12 for HDL-C and on 1 and 2 for
ApoAI (Table 2). There was no overlap in regions yielding a
LOD score greater than 1.5 between the two lipid
phenotypes.
Figure 2 shows the contribution of the four separate twin
samples to the LOD scores greater than 2. Linkage with
ApoAI on 1q21.3 (LOD¼2.1) and with HDL-C on 12q21.2
(LOD¼ 2.2) was mainly dependent on the Australian
sample (sample-specific LODs on 1p36.23 and 12q21.2
both 2.5). In contrast, three out of four twin samples
contributed to the LOD score of 2.0 found for HDL-C on
8p23.1 with the highest sample-specific LOD score being
1.4 in the adult Dutch sample.
Linkage signals observed for LDL-C and ApoB levels
generally coincided (Figure 3 and Table 2). LOD scores
greater than 2 were observed for both LDL-C and ApoB on
2p and 2q. LOD scores between 1.5 and 2 were observed for
LDL-C on 19p and 19q; the corresponding LOD scores for
ApoB varied between 0.5 and 1.0. Typing additional
markers did not appreciably change the height of these
LOD scores but shifted their position up to 4 CM (Table 2).
Linkages with LDL-C and ApoB on chromosome 2 were
mainly attributable to the Australian sample except for
2p24.1, which was also influenced by the adolescent Dutch
and Swedish sample (Figure 4). In contrast, all four samples
contributed to the linkage with LDL-C on chromosome 19
(Figure 4). These sample-specific linkage signals were
distributed over the whole chromosome. The simultaneous
analysis, however, indicated the presence of two distinct
linkage signals on the p- and the q-arm.
After fine mapping, the position of maximum LOD
scores observed for LDL-C on chromosome 2p24.1 (45 CM),
19p13.2 (33 CM) and 19q13.31 (73 CM) were close (B1 CM)
to three main candidate genes APOB (44 CM), LDLR (32 CM)
and APOE (72 CM). To assess the possible contribution of
genetic variation in these genes to the linkages observed,
tagging SNPs were measured in the twin pairs (six in APOB,
eight in LDLR and five in APOE) and haplotype analysis
was performed. Genotype distributions of all SNPs were in
agreement with Hardy–Weinberg equilibrium and popula-
tion stratification could be excluded by testing for
differences in between and within twin pair association
of SNPs with lipid phenotypes in the four samples.
Diplotypes were assigned to DZ twins only if diplotype
probability exceeded 50% (96.5% of individuals) and only
part of the Australian sample was genotyped (250 DZ
pairs). Nevertheless, linkage signals for LDL-C obtained
using this subset of DZ pairs were similar as compared to
those observed in the complete data set (Figure 5).
Accounting for the association of APOB haplotypes in the
linkage analysis reduced the LOD score for LDL-C from 1.8
to 1.0 and the QTL effect from 44 to 32% near the APOB
gene. The strongest association of APOB haplotypes with
LDL-C was observed in the Australian sample, namely for
haplotypes ACCCGA (frequency, 7.2%; P¼0.0018) and
ACCCGG (frequency, 6.4%; P¼0.012; see Subjects and
methods for SNPs measured). APOB haplotypes did not
influence the linkage signal observed 20 CM p-ter on the
same chromosome. Accounting for the effect of the LDLR
Figure 2 HDL-C and ApoAI: result of meta-analysis and analysis
individual samples. Linkage of ApoAI with chromosome 1 (a), HDL-C
with chromosome 8 (b) and HDL-C with chromosome 12 (c).
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and APOE haplotypes did not change the LOD score close
to the LDLR gene but abolished the linkage signal at the
APOE gene. Moreover, the QTL effect was reduced from 39
to 9%, thus the haplotypes tested explained the bulk of the
LDL-C QTL on 19q. As expected, especially APOE haplo-
types harbouring the e2 and, to a lesser extent, the e4 allele
Figure 3 Result of a meta-analysis of four genome-wide scans for plasma levels of LDL-C and ApoB.
Figure 4 LDL-C and ApoB: result of meta-analysis and analysis individual samples. Linkage of ApoB with chromosome 2 (a), LDL-C with
chromosome 2 (b) and LDL-C with chromosome 19 (c).
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were strongly associated with LDL-C levels in all four twin
samples (data not shown).
Discussion
To map QTLs for HDL-C, LDL-C and their main apolipo-
proteins, we performed a meta-analysis of four new
genome-wide linkage scans on DZ twins from Australia,
The Netherlands and Sweden. For HDL-C, suggestive
linkage was observed on 8p23.1 and 12q21.2, whereas for
its protein component ApoAI this was observed on 1q21.3.
The explanation for the lacking overlap in linkage signals
for HDL-C and ApoAI is not clear but may be related to
differences in underlying biology5 as described in the
Introduction. Also, the power of our study may play a role
since the QTL effects observed for ApoAI at putative HDL-C
QTLs were greater than 10%, and thus compatible with the
presence of genetic variation influencing both HDL-C and
ApoAI.
For LDL-C and its protein component ApoB, suggestive
linkage signals were coinciding on 2p25.1, 2p24.1 and
2q32.1. LOD scores between 1.7 and 1.9 for LDL-C with
lower levels of evidence for ApoB were observed on
19p13.2 and 19q13.31. Haplotype analysis of the well-
known candidate genes APOB, LDLR and APOE showed
that genetic variation in these positional candidates was
responsible for linkage of LDL-C with 2p24.1 and
19q13.31.
Thresholds for significant linkage in genome-wide scans
remain a matter of debate (suggested LOD score thresholds
include 3.6,27 3.028 and 2.029). Additional data may assist
in discriminating true from false positive results. Within
our study, linkage of LDL-C level with 2p24.1 and 19q13.31
could be attributed to variation in positional candidates
adding credibility to our linkage results and the meta-
analysis method applied. Moreover, previous studies also
Figure 5 Effect on linkage with LDL-C of accounting for APOB
haplotypes for chromosome 2 (a) and both LDLR and APOE haplotypes
for chromosome 19 (b). Accounting for the effect of APOB haplotypes
reduced the LDL-C QTL effect on 2p24.1 from 44 to 32% (a).
Accounting for the effect of LDLR and APOE haplotypes reduced the
LDL-C QTL effect on 19q13.31 from 39 to 9% (b).
Table 3 Putative quantitative traits loci influencing lipid levels from the current study that are supported by previous studies
Chromosome cMa LOD Phenotype Population and reference
2p 25 2.0, 2.0 LDL-C, ApoB Twins (this study)
20 2.2 Total cholesterol European-American sibling pairs37
2p 45 2.1, 2.1 LDL-C, ApoB Twins (this study)
40 2.2 LDL-C Old order Amish38
2q 187 2.0, 1.7 LDL-C, ApoB Twins (this study)
164 3.7 LDL-C Sardinian isolate39
12q 91 2.2 HDL-C Twins (this study)
74 4.1 HDL-C Quebec¸ois families32
115 2.1 Unesterified HDL-C Mexican-American families40
19p 33 1.9 LDL-C Twins (this study)
33 2.1 LDL-C Old order Amish38
20 3.9 Total cholesterol Pima Indians41
35 2.3 LDL size fraction Mexican-American families42
19q 73 1.7 LDL-C Twins (this study)
72 3.6 LDL-C Quebec¸ois families32
aPosition in cM originally reported transformed to our Decode genetic map.
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observed an indication for linkage at these two loci
(Table 3). Likewise, four other putative QTLs mapped in
our study are backed by previous genome scans (Table 3).
Such replication increases the probability that our and
previous findings are true positives and warrant efforts to
identify the underlying genetic variation.
Comparing different genome-wide scans, however, has
limitations and interpretation of its result is not straight-
forward. For example, various analysis methods are used,
studies may focus solely on significant evidence for linkage
not reporting potentially interesting suggestive linkages
and, importantly, there are no criteria for the maximum
distance between two mapped QTLs that can still be
considered replication. Thus, comparison of published
genome scans remains problematic and individual genome
scans generally lack power, so producing many false
negatives. Therefore, combining the available original data
rather than the published results is imperative to obtain a
complete map of QTLs for lipid phenotypes. Meta-analysis,
using our method or others’,30 will be crucial to achieve
this goal. A meta-analysis based map of QTLs for lipid
phenotypes will provide valuable information, for exam-
ple, on significant linkages previously reported for LDL-
C31,32 and HDL-C33 that have not been replicated possibly
due to lack of power of single genome scans. Also, such a
map may shed light on the suggestion that the majority of
the genetic variance of lipid phenotypes can be attributed
to well-known candidate genes.34
The meta-analysis approach presented in this study is
based on well-established methods developed for the
analysis of clinical trials.12,13 We newly applied it to
genome scans analysed using an inverse regression meth-
od22 that has asymptotically equivalent power to variance
components linkage analysis,23 and produces the SEs for
QTL effects as is necessary for meta-analysis. However, any
other linkage analysis providing effect estimates and SEs
may be used. Importantly, the meta-analysis method
provides valid estimates for the QTL effect and LOD score
in the presence of heterogeneity without compro-
mising power in the presence of homogeneity. Causes of
heterogeneity between genome-wide scans include differ-
ences in QTL effect, overall heritability, phenotyping assay,
differences in allele frequencies of short tandem repeat
markers and different marker sets. Hence, heterogeneity
between studies is a common phenomenon. All causes of
heterogeneity mentioned were present in our study.
The effect of heterogeneity in QTL effect is illustrated for
the suggestive linkage with HDL-C on 12q21.2. Linkage
was supported by the Australian sample but not by the
other samples, and the overall LOD score was lower
than that in the Australian sample alone. The increased
power of meta-analysis if multiple samples support
linkage was illustrated by the 8p23.1 result. None of the
individual samples showed suggestive linkage and this
putative QTL would have been missed. When analysed
simultaneously, however, the LOD score increased
to 2.0.
Meta-analysis may not only provide more insight into
the strength of the statistical evidence for linkage but may
also allow a more precise mapping of QTLs in some cases.
For instance, individual samples indicated the presence of
linkage with LDL-C distributed over chromosome 19
whereas meta-analysis supported the presence of two
distinct QTLs: one on the p-arm close to LDLR and one
on the q-arm close to APOE. Interestingly, our previous
combined analysis of chromosome 19 using a large part of
the currently presented data analysed within a variance
components framework did not resolve the two QTLs as
our current method does.15 A drawback of our meta-
analysis method is that either raw data are needed or,
logistically less complicated, different research groups need
to reanalyse their data according to the same protocol and
share QTL effects and SEs. However, initiatives have been
launched to assemble existing genome scans.35 Large-scale
application of meta-analysis methods may thus become
feasible in the near future.
Gene identification should follow linkage mapping of
QTLs. We were able to ascribe two putative QTLs to
haplotypes of positional candidates using a combined
analysis of linkage and association. To our knowledge this
is the first time that this was carried out successfully using
unphased haplotypes. APOB haplotypes explained part of
the linkage with LDL-C found at the APOB locus itself on
2p24.1. Factors that may have contributed to the observa-
tion that not all linkage was explained include the
presence of additional relevant but undetected genetic
variation either in APOB itself or in neighbouring genes,
the possibility that the remaining LOD score simply
constitutes a false positive signal and limitations of the
statistical method used. As to the latter, future statistical
approaches that take into account family relations when
assigning haplotypes and use complete distributions of
possible haplotypes for individuals may have higher power.
Haplotypes of positional candidates completely ex-
plained linkage with LDL-C at the APOE gene on
19q13.31. Interestingly, linkage with LDL-C at the LDLR
gene was not explained by LDLR-haplotypes. Apart from
limitations of our statistical method, it may be that genetic
variation in the LDLR gene did indeed not contribute to
the linkage result and unknown genes are involved.
Alternatively, our haplotype analysis using common SNPs
may not have been successful in capturing the relevant
genetic variation. The latter is supported by extensive data
showing that rare variants with severe or milder effects in
the LDLR gene affect LDL-C levels36 and would be
compatible with the notion that linkage is able to detect
the effects of multiple rare variants.2 The same statistical
framework may also be applied to the remaining replicated
HDL-C and LDL-C QTLs to reveal the underlying genetic
variation. In these instances, however, a positional candi-
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date approach may not suffice since the linkage regions
lack strong candidates in which case the limited current
biological knowledge may be a poor guide to select genes
for further study.
In conclusion, meta-analysis of multiple genome scans
maximises power to detect QTLs and, in addition, may
improve the precision of their location estimate. In
conjunction with combined linkage/association analysis
to test haplotypes, meta-analysis provides a powerful
approach to disentangle complex traits. Using this
approach we mapped multiple putative QTLs for lipid
levels and identified genes underlying two of them.
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